David J. Warren

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab.

Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab.

Journal: BMJ neurology open

Published: December 01, 2025

Optimizing serum adalimumab levels in maintenance therapy via proactive therapeutic drug monitoring improves markers of disease activity in Crohn's disease.

Optimizing serum adalimumab levels in maintenance therapy via proactive therapeutic drug monitoring improves markers of disease activity in Crohn's disease.

Journal: Scandinavian journal of gastroenterology

Published: October 17, 2025

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial.

Journal: Therapeutic drug monitoring

Published: April 30, 2025

Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy.

Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy.

Journal: Scandinavian journal of immunology

Published: March 28, 2025

Tumour necrosis factor inhibitors in Ulcerative colitis: real-world data on Therapeutic drug monitoring and evaluation of current treatment targets (STRIDE II).

Tumour necrosis factor inhibitors in Ulcerative colitis: real-world data on Therapeutic drug monitoring and evaluation of current treatment targets (STRIDE II).

Journal: Annals of medicine

Published: January 06, 2025

Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.

Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.

Journal: Cell reports. Medicine

Published: January 03, 2025

Serological screening for coeliac disease in an adult general population: the HUNT study.

Serological screening for coeliac disease in an adult general population: the HUNT study.

Journal: Gut

Published: September 14, 2024

A simple automated assay format for measuring multiple immune checkpoint inhibitors.

A simple automated assay format for measuring multiple immune checkpoint inhibitors.

Journal: Journal of pharmaceutical and biomedical analysis

Published: August 27, 2024

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Journal: RMD open

Published: August 16, 2024

Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.

Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.

Journal: Journal for immunotherapy of cancer

Published: March 08, 2024

The Prevalence and Rate of Undiagnosed Celiac Disease in an Adult General Population, the Trøndelag Health Study, Norway.

The Prevalence and Rate of Undiagnosed Celiac Disease in an Adult General Population, the Trøndelag Health Study, Norway.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: February 03, 2024

Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients.

Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients.

Journal: BMJ open

Published: January 09, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026